QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
QQQ   317.08 (-1.13%)
AAPL   164.92 (+0.03%)
MSFT   282.30 (+0.71%)
META   168.53 (-1.01%)
GOOGL   116.63 (-0.57%)
AMZN   137.83 (-1.13%)
TSLA   850.00 (-2.44%)
NVDA   170.86 (-3.97%)
NIO   19.17 (-4.96%)
BABA   91.19 (+0.39%)
AMD   95.54 (-4.53%)
MU   59.15 (-3.74%)
T   18.10 (+0.56%)
CGC   2.87 (-12.50%)
GE   74.93 (-0.33%)
F   15.19 (-3.74%)
DIS   108.13 (-0.90%)
AMC   22.45 (-6.30%)
PYPL   94.48 (-1.85%)
PFE   49.78 (+0.42%)
NFLX   229.94 (-1.52%)
NASDAQ:JAGX

Jaguar Health - JAGX News Headlines

$0.28
+0.01 (+3.74%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$0.27
$0.30
50-Day Range
$0.25
$0.36
52-Week Range
$0.25
$4.08
Volume
11.96 million shs
Average Volume
3.30 million shs
Market Capitalization
$22.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Get Jaguar Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

JAGX Media Mentions By Week

JAGX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

JAGX
News Sentiment

0.56

0.35

Average
Medical
News Sentiment

JAGX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

JAGX Articles
This Week

4

2

JAGX Articles
Average Week



SourceHeadline
finance.yahoo.com logoJaguar Health Announces Issuance of U.S. Patent 11,389,424, a Methods and Compositions Patent for Treating Chemotherapy-Induced Diarrhea
finance.yahoo.com - August 9 at 12:20 PM
MarketBeat logoJaguar Health (NASDAQ:JAGX) Now Covered by Analysts at StockNews.com
americanbankingnews.com - August 9 at 4:23 AM
msn.com logoThis Rare, Street-Legal Jaguar XJR-15 Could Sell for up to $1.4 Million at Auction
msn.com - August 4 at 2:05 PM
MarketBeat logoStockNews.com Initiates Coverage on Jaguar Health (NASDAQ:JAGX)
americanbankingnews.com - August 2 at 1:22 AM
MarketBeat logoJaguar Health (NASDAQ:JAGX) Research Coverage Started at StockNews.com
americanbankingnews.com - July 25 at 1:26 AM
uk.investing.com logoShort Volatility Alert: Jaguar Health, Inc.
uk.investing.com - July 6 at 11:44 PM
finance.yahoo.com logoJaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions
finance.yahoo.com - July 5 at 9:07 AM
seekingalpha.com logoJaguar stock rises on license deal with SynWorld for Canalevia in China
seekingalpha.com - June 29 at 5:54 PM
finance.yahoo.com logoJaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China
finance.yahoo.com - June 29 at 9:26 AM
benzinga.com logoThinking about buying stock in Blue Hat Interactive, Vroom, Revlon, Roblox, or Jaguar Health?
benzinga.com - June 24 at 4:45 PM
finance.yahoo.com logoJaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi
finance.yahoo.com - June 22 at 11:58 AM
finance.yahoo.com logoJaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1
finance.yahoo.com - June 21 at 10:20 AM
finanznachrichten.de logoJaguar Health, Inc.: Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients
finanznachrichten.de - June 13 at 12:17 PM
apnews.com logoJaguar Health Announces Publication of Onco’Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients
apnews.com - June 13 at 12:17 PM
seekingalpha.com logoJaguar Health highlights importance of controlling diarrhea in cancer patients
seekingalpha.com - June 13 at 12:17 PM
finance.yahoo.com logoJaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients
finance.yahoo.com - June 13 at 12:17 PM
finanznachrichten.de logoJaguar Health, Inc.: Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders
finanznachrichten.de - June 10 at 6:18 PM
finance.yahoo.com logoJaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders
finance.yahoo.com - June 10 at 6:18 PM
finanznachrichten.de logoJaguar Health, Inc.: Jaguar Health to Participate in BIO International Convention
finanznachrichten.de - June 10 at 8:48 AM
finance.yahoo.com logoJaguar Health to Participate in BIO International Convention (BIO 2022)
finance.yahoo.com - June 10 at 8:48 AM
msn.com logoTwo Psychedelics Drug Development Companies Work To Produce Novel Plant-Based Compounds For Mental Health Disorders
msn.com - June 9 at 5:46 PM
finance.yahoo.com logoFilament Health and Jaguar Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications
finance.yahoo.com - June 9 at 12:45 PM
finance.yahoo.com logoJaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications
finance.yahoo.com - June 9 at 12:45 PM
seekingalpha.com logoJaguar Health's Italian firm applies for orphan drug designation for crofelemer to EMA
seekingalpha.com - May 25 at 9:57 AM
finance.yahoo.com logoJaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition
finance.yahoo.com - May 25 at 9:57 AM
finance.yahoo.com logoJaguar Health Announces Presentation of an Investigator-initiated Evaluation of Crofelemer for a Severe Congenital Diarrheal Disorder at 2022 Digestive Disease Week
finance.yahoo.com - May 24 at 8:48 AM
finance.yahoo.com logoJaguar Health Announces Launch of the First U.S. Canine Cancer Registry and Canine Cancer Care Index
finance.yahoo.com - May 23 at 9:52 AM
finance.yahoo.com logoMedia Advisory: Jaguar Health Canine Cancer: Take C.H.A.R.G.E. Launch Event in NYC on Monday, May 23rd!
finance.yahoo.com - May 17 at 5:58 PM
finanznachrichten.de logoJaguar Health, Inc.: TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
finanznachrichten.de - May 11 at 4:06 PM
finance.yahoo.com logoTAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
finance.yahoo.com - May 11 at 4:06 PM
finanznachrichten.de logoJaguar Health, Inc.: Jaguar Health Announces Launch of Mytesi Telehealth Program
finanznachrichten.de - May 11 at 11:05 AM
finance.yahoo.com logoJaguar Health Announces Launch of Mytesi Telehealth Program
finance.yahoo.com - May 11 at 11:05 AM
seekingalpha.com logoJaguar Health, Inc. (JAGX) CEO Lisa Conte on Q1 2022 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 1:37 PM
finanznachrichten.de logoJaguar Health, Inc.: Jaguar Health Provides Company Updates and Reports 2022 First Quarter Financials
finanznachrichten.de - May 10 at 8:36 AM
finance.yahoo.com logoJaguar Health Provides Company Updates and Reports 2022 First Quarter Financials
finance.yahoo.com - May 10 at 8:36 AM
seekingalpha.com logoJaguar Health Q1 2022 Earnings Preview
seekingalpha.com - May 9 at 5:35 PM
finanznachrichten.de logoJaguar Health, Inc.: Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635
finanznachrichten.de - May 6 at 8:00 PM
finance.yahoo.com logoUPDATED RELEASE: Jaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
finance.yahoo.com - May 5 at 7:12 PM
finance.yahoo.com logoJaguar Health to Host Investor Webcast Tuesday, May 10th at 8:30 AM Eastern Time Regarding Q1 2022 Financials & Corporate Updates
finance.yahoo.com - May 5 at 9:11 AM
finance.yahoo.com logoJaguar Health Completes Final Regulatory Filing for Conditional New Animal Drug Approval of Canalevia (Crofelemer) to Treat Exercise-induced Diarrhea (EID) in Dogs
finance.yahoo.com - May 3 at 2:16 PM
finance.yahoo.com logoJaguar Animal Health Announces Commercial Availability of Plant-based Canalevia-CA1 (Crofelemer) Prescription Drug for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
finance.yahoo.com - April 27 at 3:21 PM
finance.yahoo.com logoJaguar Health to Present at the NobleCon18 Investor Conference on April 21, 2022
finance.yahoo.com - April 20 at 1:12 PM
finanznachrichten.de logoJaguar Health, Inc.: Jaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635
finanznachrichten.de - April 15 at 6:09 PM
finance.yahoo.com logoJaguar Health Announces Replenishment of New Employee Inducement Plan Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - April 15 at 6:09 PM
finance.yahoo.com logoJaguar Animal Health to Host Dinner & Tableside Discussion for U.S. Veterinary Oncologists About Chemotherapy-Induced Diarrhea (CID) in Dogs on April 12th, the Final Day of the Veterinary Cancer Society (VCS) Mid-Year Conference in Puerto Vallarta, Mexico
finance.yahoo.com - April 6 at 10:51 AM
finanznachrichten.de logoJaguar Health, Inc.: Jaguar Health Announces Appointment of Pravin Chaturvedi, Ph.D., as Chief Scientific Officer
finanznachrichten.de - April 5 at 8:43 AM
finance.yahoo.com logoJaguar Health Announces Appointment of Pravin Chaturvedi, Ph.D., as Chief Scientific Officer
finance.yahoo.com - April 5 at 8:43 AM
uk.investing.com logoHere's Why Jaguar Health Shares Are Rising
uk.investing.com - April 4 at 5:40 PM
seekingalpha.com logoJaguar Health pares off gains in early trading after March 31 rally on back of license deal
seekingalpha.com - April 1 at 10:32 AM
uk.investing.com logoHere's Why Jaguar Health Shares Are Popping Off
uk.investing.com - March 31 at 7:06 PM
Get Jaguar Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:JAGX) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.